1. Veterinary Monoclonal Antibodies Market: Overview

1.1. Study Assumption and Market Definition

1.2. Scope of the Study

1.3. Executive Summary

1.3.1. Market Size and Market Share by Segments, Region and Country

2. Veterinary Monoclonal Antibodies Market: Market Variables and Key Insights

2.1. Veterinary Monoclonal Antibodies Market Dynamics

2.1.1. Market Trends Analysis

2.1.2. Market Drivers Analysis

2.1.3. Market Challenges Analysis

2.1.4. Market Opportunities Analysis

2.2. Veterinary Monoclonal Antibodies Market Business Tools Analysis

2.2.1. PORTER’s Five Forces Analysis

2.2.2. PESTLE Analysis

2.3. Technology Roadmap

2.4. Value Chain Analysis

2.5. Regulatory Landscape by Region

2.5.1. North America

2.5.2. Europe

2.5.3. Asia Pacific

2.5.4. Middle East and Africa

2.5.5. South America

2.6. Analysis of Government Schemes and Initiatives on the Global Veterinary Monoclonal Antibodies Market

3. Veterinary Monoclonal Antibodies Market: Global Market Size, Trend Analysis and Forecast (2025-2032) in Value (USD Billion)

3.1. Global Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

3.1.1. Dogs (Canine)

3.1.2. Cats (Feline)

3.1.3. Livestock Animals

3.1.4. Other Companion Animals

3.2. Global Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

3.2.1. Anti-IL-31 Monoclonal Antibodies

3.2.2. Anti-NGF Monoclonal Antibodies

3.2.3. Immune-Modulating mAbs

3.2.4. Other Targeted mAbs

3.3. Global Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

3.3.1. Dermatology (Atopic Dermatitis)

3.3.2. Pain Management / Osteoarthritis

3.3.3. Infectious Diseases

3.3.4. Oncology

3.3.5. Other Therapeutic Areas

3.4. Global Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

3.4.1. Injectable Monoclonal Antibodies

3.4.2. Subcutaneous Formulations

3.4.3. Other Delivery Methods

3.5. Global Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

3.5.1. Veterinary Hospitals

3.5.2. Veterinary Clinics

3.5.3. Research Institutions

3.5.4. Other Animal Healthcare Providers

3.6. Global Veterinary Monoclonal Antibodies Market Size and Forecast, By Country (2025-2032)

3.6.1. North America

3.6.2. Europe

3.6.3. Asia Pacific

3.6.4. Middle East & Africa

3.6.5. South America

4. Veterinary Monoclonal Antibodies Market: North America Market Size, Trend Analysis and Forecast (2025-2032) in Value (USD Billion)

4.1. North America Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

4.1.1. Dogs (Canine)

4.1.2. Cats (Feline)

4.1.3. Livestock Animals

4.1.4. Other Companion Animals

4.2. North America Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

4.2.1. Anti-IL-31 Monoclonal Antibodies

4.2.2. Anti-NGF Monoclonal Antibodies

4.2.3. Immune-Modulating mAbs

4.2.4. Other Targeted mAbs

4.3. North America Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

4.3.1. Dermatology (Atopic Dermatitis)

4.3.2. Pain Management / Osteoarthritis

4.3.3. Infectious Diseases

4.3.4. Oncology

4.3.5. Other Therapeutic Areas

4.4. North America Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

4.4.1. Injectable Monoclonal Antibodies

4.4.2. Subcutaneous Formulations

4.4.3. Other Delivery Methods

4.5. North America Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

4.5.1. Veterinary Hospitals

4.5.2. Veterinary Clinics

4.5.3. Research Institutions

4.5.4. Other Animal Healthcare Providers

4.6. North America Veterinary Monoclonal Antibodies Market Size and Forecast, by Country (2025-2032)

4.6.1. United States

4.6.2. Mexico

4.6.3. Canada

4.6.1.1. United States Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

4.6.1.2. United States Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

4.6.1.3. United States Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

4.6.1.4. United States Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

4.6.1.5. United States Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

4.6.2.1. Mexico Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

4.6.2.2. Mexico Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

4.6.2.3. Mexico Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

4.6.2.4. Mexico Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

4.6.2.5. Mexico Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

4.6.3.1. Canada Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

4.6.3.2. Canada Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

4.6.3.3. Canada Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

4.6.3.4. Canada Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

4.6.3.5. Canada Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

5. Veterinary Monoclonal Antibodies Market: Europe Market Size, Trend Analysis and Forecast (2025-2032) in Value (USD Billion)

5.1. Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

5.1.1. Dogs (Canine)

5.1.2. Cats (Feline)

5.1.3. Livestock Animals

5.1.4. Other Companion Animals

5.2. Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

5.2.1. Anti-IL-31 Monoclonal Antibodies

5.2.2. Anti-NGF Monoclonal Antibodies

5.2.3. Immune-Modulating mAbs

5.2.4. Other Targeted mAbs

5.3. Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

5.3.1. Dermatology (Atopic Dermatitis)

5.3.2. Pain Management / Osteoarthritis

5.3.3. Infectious Diseases

5.3.4. Oncology

5.3.5. Other Therapeutic Areas

5.4. Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

5.4.1. Injectable Monoclonal Antibodies

5.4.2. Subcutaneous Formulations

5.4.3. Other Delivery Methods

5.5. Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

5.5.1. Veterinary Hospitals

5.5.2. Veterinary Clinics

5.5.3. Research Institutions

5.5.4. Other Animal Healthcare Providers

5.6. Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By Country (2025-2032)

5.6.1. United Kingdom

5.6.2. France

5.6.3. Germany

5.6.4. Italy

5.6.5. Spain

5.6.6. Sweden

5.6.7. Russia

5.6.8. Rest of Europe

5.6.1.1. United Kingdom Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

5.6.1.2. United Kingdom Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

5.6.1.3. United Kingdom Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

5.6.1.4. United Kingdom Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

5.6.1.5. United Kingdom Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

5.6.2.1. France Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

5.6.2.2. France Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

5.6.2.3. France Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

5.6.2.4. France Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

5.6.2.5. France Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

5.6.3.1. Germany Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

5.6.3.2. Germany Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

5.6.3.3. Germany Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

5.6.3.4. Germany Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

5.6.3.5. Germany Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

5.6.4.1. Italy Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

5.6.4.2. Italy Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

5.6.4.3. Italy Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

5.6.4.4. Italy Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

5.6.4.5. Italy Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

5.6.5.1. Spain Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

5.6.5.2. Spain Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

5.6.5.3. Spain Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

5.6.5.4. Spain Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

5.6.5.5. Spain Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

5.6.6.1. Sweden Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

5.6.6.2. Sweden Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

5.6.6.3. Sweden Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

5.6.6.4. Sweden Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

5.6.6.5. Sweden Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

5.6.7.1. Russia Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

5.6.7.2. Russia Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

5.6.7.3. Russia Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

5.6.7.4. Russia Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

5.6.7.5. Russia Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

5.6.8.1. Rest of Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

5.6.8.2. Rest of Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

5.6.8.3. Rest of Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

5.6.8.4. Rest of Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

5.6.8.5. Rest of Europe Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

6. Veterinary Monoclonal Antibodies Market: Asia Pacific Market Size, Trend Analysis and Forecast (2025-2032) in Value (USD Billion)

6.1. Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

6.1.1. Dogs (Canine)

6.1.2. Cats (Feline)

6.1.3. Livestock Animals

6.1.4. Other Companion Animals

6.2. Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

6.2.1. Anti-IL-31 Monoclonal Antibodies

6.2.2. Anti-NGF Monoclonal Antibodies

6.2.3. Immune-Modulating mAbs

6.2.4. Other Targeted mAbs

6.3. Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

6.3.1. Dermatology (Atopic Dermatitis)

6.3.2. Pain Management / Osteoarthritis

6.3.3. Infectious Diseases

6.3.4. Oncology

6.3.5. Other Therapeutic Areas

6.4. Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

6.4.1. Injectable Monoclonal Antibodies

6.4.2. Subcutaneous Formulations

6.4.3. Other Delivery Methods

6.5. Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

6.5.1. Veterinary Hospitals

6.5.2. Veterinary Clinics

6.5.3. Research Institutions

6.5.4. Other Animal Healthcare Providers

6.6. Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By Country (2025-2032)

6.6.1. China

6.6.2. South Korea

6.6.3. Japan

6.6.4. India

6.6.5. Australia

6.6.6. ASEAN

6.6.7. Rest of Asia Pacific

6.6.1.1. China Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

6.6.1.2. China Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

6.6.1.3. China Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

6.6.1.4. China Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

6.6.1.5. China Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

6.6.2.1. South Korea Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

6.6.2.2. South Korea Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

6.6.2.3. South Korea Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

6.6.2.4. South Korea Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

6.6.2.5. South Korea Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

6.6.3.1. Japan Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

6.6.3.2. Japan Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

6.6.3.3. Japan Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

6.6.3.4. Japan Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

6.6.3.5. Japan Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

6.6.4.1. India Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

6.6.4.2. India Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

6.6.4.3. India Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

6.6.4.4. India Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

6.6.4.5. India Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

6.6.5.1 Australia Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

6.6.5.2 Australia Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

6.6.5.3 Australia Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

6.6.5.4 Australia Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

6.6.5.5 Australia Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

6.6.6.1. ASEAN Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

6.6.6.2. ASEAN Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

6.6.6.3. ASEAN Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

6.6.6.4. ASEAN Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

6.6.6.5. ASEAN Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

6.6.7.1. Rest of Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

6.6.7.2. Rest of Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

6.6.7.3. Rest of Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

6.6.7.4. Rest of Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

6.6.7.5. Rest of Asia Pacific Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

7. Veterinary Monoclonal Antibodies Market: Middle East & Africa Market Size, Trend Analysis and Forecast (2025-2032) in Value (USD Billion)

7.1. Middle East & Africa Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

7.1.1. Dogs (Canine)

7.1.2. Cats (Feline)

7.1.3. Livestock Animals

7.1.4. Other Companion Animals

7.2. Middle East & Africa Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

7.2.1. Anti-IL-31 Monoclonal Antibodies

7.2.2. Anti-NGF Monoclonal Antibodies

7.2.3. Immune-Modulating mAbs

7.2.4. Other Targeted mAbs

7.3. Gel Middle East & Africa Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

7.3.1. Dermatology (Atopic Dermatitis)

7.3.2. Pain Management / Osteoarthritis

7.3.3. Infectious Diseases

7.3.4. Oncology

7.3.5. Other Therapeutic Areas

7.4. Middle East & Africa Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

7.4.1. Injectable Monoclonal Antibodies

7.4.2. Subcutaneous Formulations

7.4.3. Other Delivery Methods

7.5. Middle East & Africa Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

7.5.1. Veterinary Hospitals

7.5.2. Veterinary Clinics

7.5.3. Research Institutions

7.5.4. Other Animal Healthcare Providers

7.6. Middle East & Africa Veterinary Monoclonal Antibodies Market Size and Forecast, by Country (2025-2032)

7.6.1. South Africa

7.6.2. GCC

7.6.3. Turkey

7.6.4. Rest of ME&A

7.6.1.1. South Africa Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

7.6.1.2. South Africa Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

7.6.1.3. South Africa Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

7.6.1.4. South Africa Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

7.6.1.5. South Africa Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

7.6.2.1. GCC Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

7.6.2.2. GCC Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

7.6.2.3. GCC Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

7.6.2.4. GCC Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

7.6.2.5. GCC Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

7.6.3.1. Turkey Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

7.6.3.2. Turkey Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

7.6.3.3. Turkey Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

7.6.3.4. Turkey Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

7.6.3.5. Turkey Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

7.6.4.1. Rest of ME&A Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

7.6.4.2. Rest of ME&A Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

7.6.4.3. Rest of ME&A Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

7.6.4.4. Rest of ME&A Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

7.6.4.5. Rest of ME&A Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

8. Veterinary Monoclonal Antibodies Market: South America Market Size, Trend Analysis and Forecast (2025-2032) in Value (USD Billion)

8.1. South America Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

8.1.1. Dogs (Canine)

8.1.2. Cats (Feline)

8.1.3. Livestock Animals

8.1.4. Other Companion Animals

8.2. South America Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

8.2.1. Anti-IL-31 Monoclonal Antibodies

8.2.2. Anti-NGF Monoclonal Antibodies

8.2.3. Immune-Modulating mAbs

8.2.4. Other Targeted mAbs

8.3. South America Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

8.3.1. Dermatology (Atopic Dermatitis)

8.3.2. Pain Management / Osteoarthritis

8.3.3. Infectious Diseases

8.3.4. Oncology

8.3.5. Other Therapeutic Areas

8.4. South America Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

8.4.1. Injectable Monoclonal Antibodies

8.4.2. Subcutaneous Formulations

8.4.3. Other Delivery Methods

8.5. South America Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

8.5.1. Veterinary Hospitals

8.5.2. Veterinary Clinics

8.5.3. Research Institutions

8.5.4. Other Animal Healthcare Providers

8.6. South America Veterinary Monoclonal Antibodies Market Size and Forecast, by Country (2025-2032)

8.6.1. Brazil

8.6.2. Argentina

8.6.3. Rest of South America

8.6.1.1. Brazil Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

8.6.1.2. Brazil Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

8.6.1.3. Brazil Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

8.6.1.4. Brazil Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

8.6.1.5. Brazil Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

8.6.2.1. Argentina Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

8.6.2.2. Argentina Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

8.6.2.3. Argentina Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

8.6.2.4. Argentina Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

8.6.2.5. Argentina Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

8.6.3.1. Rest of South America Veterinary Monoclonal Antibodies Market Size and Forecast, By Animal Type (2025-2032)

8.6.3.2. Rest of South America Veterinary Monoclonal Antibodies Market Size and Forecast, By Product Type (2025-2032)

8.6.3.3. Rest of South America Veterinary Monoclonal Antibodies Market Size and Forecast, By Therapy Area (2025-2032)

8.6.3.4. Rest of South America Veterinary Monoclonal Antibodies Market Size and Forecast, By Route of Administration (2025-2032)

8.6.3.5. Rest of South America Veterinary Monoclonal Antibodies Market Size and Forecast, By End User (2025-2032)

9. Veterinary Monoclonal Antibodies Market: Competitive Landscape

9.1. JBI Competition Matrix

9.2. Competitive Landscape

9.3. Key Players Benchmarking

1. Company Name

2. Product Segment

3. End-User Segment

4. Revenue Details

5. Market Share

6. Company Locations

9.4. Market Categorisation

1. Market Leaders

2. Market Followers

3. Market Emerging Players

4. Mergers and Acquisitions Details

9.5. Company Profiles of Leading Market Players (Company Overview, Product Portfolio, Financial Overview, SWOT Analysis, Strategies, Recent Developments, (Based on Availability))

1. Company Name

2. Product Segment

3. End-User Segment

4. Revenue Details

5. Market Share

6. Company Locations

9.5.1. Zoetis Inc.

9.5.2. Elanco Animal Health Incorporated

9.5.3. Merck & Co., Inc.

9.5.4. Boehringer Ingelheim Animal Health

9.5.5. Ceva Santé Animale

9.5.6. Vetoquinol S.A.

9.5.7. Dechra Pharmaceuticals PLC

9.5.8. Phibro Animal Health Corporation

9.5.9. Biogenesis Bago S.A.

9.5.10. Vetigenics Inc.

9.5.11. Animab AB

9.5.12. VETmAb BIO

9.5.13. WuXi Biologics

9.5.14. Bio‑Rad Laboratories, Inc.

9.5.15. SouthernBiotech

10. Veterinary Monoclonal Antibodies Market: Strategic Recommendations/ Market Opportunities

11. Veterinary Monoclonal Antibodies Market: Key Takeaways

12. Veterinary Monoclonal Antibodies Market: Research Methodology

Note:

• The table of contents is as per our syndicate report aimed at a broader audience, can be modified as per requirements.

TOC can be amended before delivery as per research updates by the analysts.

REQUEST SAMPLE

REPORT TITLE:

Omega 3 Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, Source and Application: Global Opportunity and Industry Forecast (2025-2032)